Healthy Smokers Clinical Trial
The purpose of this study is to compare the relative bioavailability of nicotine following
single application of a new transdermal formulation to that of a reference formulation.
4 single 24hour applications separated by 48hour intervals.
n/a
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT00159302 -
Biomarkers of iNOS Activity in COPD, Asthma, Healthy Control
|
||
| Completed |
NCT03728530 -
Effect Of Deep Breathing Exercises In Smokers
|
N/A | |
| Completed |
NCT02089308 -
Nicotine Patch - Bioequivalence Study
|
Phase 1 | |
| Completed |
NCT01574898 -
Pilot Pharmacokinetic Study of New Nicotine Lozenge Formulations
|
Phase 1 | |
| Completed |
NCT01658215 -
Nicotine Patch - Multidose Bioequivalence Study
|
Phase 1 | |
| Terminated |
NCT00753870 -
Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers
|
Phase 1 | |
| Completed |
NCT01188239 -
A Structured Protocol to Evaluate Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette)
|
N/A | |
| Completed |
NCT01164072 -
Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette)
|
N/A | |
| Completed |
NCT01194583 -
Efficacy and Safety of an Electronic Nicotine Delivery Device (E-Cigarette) Without Nicotine Cartridges
|
N/A |